LIFEPharma, part of VPS Healthcare, will invest AED 700 million to develop a pharmaceutical platform at KEZAD.
The agreement was signed with AD Ports Group during Make it in the Emirates 2026. The facility will allocate AED300 million for vaccine production, AED 200 million for oncology treatments and AED 200 million for peptides, biologics and injectables.
The platform is expected to generate AED 2 billion in GDP impact and create over 1,000 jobs.
The project aligns with Operation 300bn, targeting an increase in industrial GDP contribution to AED 300 billion by 2031.
Gulf Economist Staff Writer